Grifols S.A. ADR Stock
Price
Target price
€5.80
€5.80
-
-
-
-
25.04.24 / Frankfurt
WKN: A1J1E2 / Symbol: GRFS / Name: Grifols / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Grifols S.A. ADR in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Grifols S.A. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Grifols S.A. ADR | - | -3.333% | 4.505% | -11.450% | -37.297% | -61.188% | -65.269% |
| Beximco Pharmaceuticals Ltd. GDR | -0.930% | 2.381% | -1.376% | -4.444% | -2.273% | -55.670% | -21.818% |
| Cellectar BioSciences Inc. | 3.550% | -2.083% | -21.667% | 110.448% | 23.684% | -77.258% | - |
| Arca Biopharma | -5.290% | 5.844% | 98.176% | 75.741% | 109.646% | 10.884% | -94.250% |
Comments
Grifols, S.A. (NASDAQ: GRFS) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "sell" rating.
Show more
Ratings data for GRFS provided by MarketBeat
